Applied Therapeutics Profit Margin

Applied Therapeutics (APLT) currently reports a profit margin of -1815.62% as of September 2025. That compares with 88772.51% in the prior-year period — down 102.0% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Applied Therapeutics's profit margin history and peer comparisons.

Applied Therapeutics's profit margin decreased from 88772.51% to -1815.62% — a 102.0% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Therapeutics's profit margin of -1815.62% is lower than the Healthcare sector average of 15.29%. That is roughly 11972.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Applied Therapeutics's current -1815.62% should be judged against Healthcare norms (sector average: 15.29%) and against APLT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1815.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Applied Therapeutics, and consider following APLT for alerts when major investors trade the stock.